• Home
  • 16th European Epilepsy Congress

EEC 2026


Athens, Greece

16th European Epilepsy Congress
Explore more Epilepsy congress materials
Material Type

Results(11)

Epilepsy
Burden of Illness in Developmental and Epileptic Encephalopathies Beyond Dravet Syndrome, Lennox-Gastaut Syndrome, and Tuberous Sclerosis Complex: A Systematic Literature Review
Author(s): Sanket Shah, Miranda Harrison, Paranjoy Saharia et al.
Characterisation of Spike-and-Wave Discharge Modulation by Ethosuximide in the GAERS Model of Absence Seizures With Extended Homecage EEG Monitoring
Author(s): Venceslas Duveau, Alexis Evrard, Natalie F Shanks et al.
Effect of Cannabidiol on Measured Glomerular Filtration Rate in Healthy Participants: A Phase 1, Open-Label, Single-Site Study
Author(s): Svetlana Markova, Hongwei Xue, Patricia Chandler et al.
Cannabidiol Effectiveness in Patients with Lennox-Gastaut Syndrome of Diverse Aetiologies Compared with External Placebo Control: A Post Hoc Analysis from the US Expanded Access Program
Author(s): Eric Marsh, Karthik Rajasekaran, Catherine L Passariello et al.
Phase 1, Open-Label, Fixed-Sequence, Bidirectional, Pharmacokinetic Drug–Drug Interaction Study Between Cannabidiol and Cenobamate in Healthy Adult Participants
Author(s): Arjun Vijan, Hongwei Xue, Patricia Chandler et al.
Patterns of Concomitant Medication Use Among Adult Patients Receiving Cannabidiol: Longitudinal Evaluation of Prescription Data From the German Insight Health Database
Author(s): Paul Martin Fuhrmann, Aylin Pichler, Ava Arshadipour et al.
Cannabidiol Efficacy in Patients With Lennox-Gastaut Syndrome With Developmental and Epileptic Encephalopathy-Associated Genetic Variants: A Subgroup Analysis
Author(s): Elizabeth A Thiele, Michael Boffa, Daniel Checketts et al.
Effectiveness and Real-World Use of Cannabidiol for the Treatment of Dravet Syndrome, Lennox-Gastaut Syndrome and Tuberous Sclerosis Complex in Routine Clinical Practice in Italy: Data From an Ongoing, Multicentre, Prospective, Observational Study
Author(s): Giuseppe d’Orsi, Francesca Operto, Maria Spanò et al.
Tuberous Sclerosis Complex–Associated Neuropsychiatric Disorders (TAND) Outcomes Following Adjunctive Cannabidiol Treatment: 6-Month Intermediate Analysis of the EpiCom Trial
Author(s): Agnies van Eeghen, Sarah ML Wilson, Stevie Roszkowski et al.